Emerging cytotoxic alkaloids in the battle against cancer: Overview of molecular mechanisms
Considered as the second deadliest disease globally, cancer has captured the attention of
researchers who have been trying with perseverance to decode its hidden aspects, to find …
researchers who have been trying with perseverance to decode its hidden aspects, to find …
Epidemiology and treatment patterns for locally advanced or metastatic urothelial carcinoma: a systematic literature review and gap analysis
Z Hepp, SN Shah, K Smoyer, P Vadagam - Journal of Managed Care & …, 2021 - jmcp.org
BACKGROUND: Several immuno-oncology (IO) agents targeting programmed death-1 or
programmed death-ligand 1 (PD-1/L1) are approved second-line therapy options for …
programmed death-ligand 1 (PD-1/L1) are approved second-line therapy options for …
Safety and efficacy of atezolizumab in understudied populations with pretreated urinary tract carcinoma: subgroup analyses of the SAUL study in real-world practice
AS Merseburger, D Castellano, T Powles… - The Journal of …, 2021 - auajournals.org
Purpose: Atezolizumab is an established treatment option for pretreated urothelial
carcinoma, demonstrating efficacy in phase II/III trials. The SAUL study enrolled a broader …
carcinoma, demonstrating efficacy in phase II/III trials. The SAUL study enrolled a broader …
Efficacy and safety of chemotherapy regimens in advanced or metastatic bladder and urothelial carcinomas: an updated network meta-analysis
HC Qu, Y Huang, ZY Mu, H Lv, QP Xie… - Frontiers in …, 2020 - frontiersin.org
Background: Gemcitabine plus cisplatin (GC) and methotrexate, vinblastine, adriamycin, and
cisplatin (MVAC) have been the first-line treatments for advanced or metastatic urothelial …
cisplatin (MVAC) have been the first-line treatments for advanced or metastatic urothelial …
Vinflunine in the treatment of relapsed metastatic urothelial cancer: A systematic review and meta-analysis of real-world series
A Bamias, A Hegele, J Medioni, D Castellano… - Critical Reviews in …, 2019 - Elsevier
Background Vinflunine (VFL) is approved in Europe as second-line treatment of metastatic
urothelial cancer after failure of platinum-containing therapy. We performed a systematic …
urothelial cancer after failure of platinum-containing therapy. We performed a systematic …
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC …
R Passalacqua, S Lazzarelli, M Donini, R Montironi… - BMC cancer, 2017 - Springer
Background Vinflunine is the only chemotherapeutic agent shown to improve survival in
platinum-refractory patients with metastatic transitional cell carcinoma of the urothelium …
platinum-refractory patients with metastatic transitional cell carcinoma of the urothelium …
Vinflunine in the treatment of upper tract Urothelial carcinoma–subgroup analysis of an observational study
H Heers, P De Geeter, PJ Goebell, U Matz… - Anticancer …, 2017 - ar.iiarjournals.org
Background/Aim: Despite an expected prognostic disadvantage for upper tract versus lower
tract metastatic urothelial carcinomas (UTUC/LTUC), only few studies have been conducted …
tract metastatic urothelial carcinomas (UTUC/LTUC), only few studies have been conducted …
[HTML][HTML] Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survival
T Kuş, G Aktaş - Turkish Journal of Urology, 2017 - ncbi.nlm.nih.gov
Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer
survival - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
survival - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in …
SC Brousell, JJ Fantony, MG Van Noord… - Core …, 2018 - Taylor & Francis
Background: A systematic review and meta-analysis of the use of systemic vinflunine (VIN)
in the treatment of urothelial carcinoma (UC) was performed to evaluate its efficacy based on …
in the treatment of urothelial carcinoma (UC) was performed to evaluate its efficacy based on …
[HTML][HTML] Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
X Liu, Y Lang, Q Chai, Y Lin, Y Liao… - Frontiers in Pharmacology, 2022 - frontiersin.org
Purpose: According to the IMvigor130 trial, adding atezolizumab to platinum-based
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …
chemotherapy was effective in the treatment of metastatic urothelial cancer (mUC). Based on …